---
sidebar_position: 122
---
           <p class="stitle-article-norm">Entry into force and date of application</p>
   <p class="norm">1.&nbsp;&nbsp;This Regulation shall enter into force on the twentieth day following that of its publication in the <span class="italics">Official Journal of the European Union</span>.</p>
   <p class="norm">2.&nbsp;&nbsp;It shall apply from 26 May 2020.</p>
   <p class="norm">3.&nbsp;&nbsp;By way of derogation from paragraph&nbsp;2:</p>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(a)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">Articles&nbsp;35 to 50 shall apply from 26 
November 2017. However, from that date until 26 May 2020, the 
obligations on notified bodies pursuant to Articles&nbsp;35 to 50 shall 
apply only to those bodies which submit an application for designation 
in accordance with <a href='../CHAPTER IV/Article 38 - Application by conformity assessment bodies for designation'> Article 38</a>;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(b)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">Articles&nbsp;101 and 103 shall apply from 26 November 2017;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(c)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm"><a href='../CHAPTER VIII/Article 102 - Cooperation'> Article 102</a> shall apply from 26 May 2018;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(d)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">without prejudice to the obligations on the 
Commission pursuant to <a href='../CHAPTER III/Article 34 - Functionality of Eudamed'> Article 34</a>, where, due to circumstances that
 could not reasonably have been foreseen when drafting the plan referred
 to in <a href='../CHAPTER III/Article 34 - Functionality of Eudamed'> Article 34</a>(1), Eudamed is not fully functional on 
26&nbsp;May 2020, the obligations and requirements that relate to 
Eudamed shall apply from the date corresponding to six&nbsp;months after
 the date of publication of the notice referred to in 
<a href='../CHAPTER III/Article 34 - Functionality of Eudamed'> Article 34</a>(3). The provisions referred to in the preceding sentence
 are:</p>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER III/Article 29 - Registration of devices'> Article 29</a>,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER III/Article 31 - Registration of manufacturers authorised representatives and importers'> Article 31</a>,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER III/Article 32 - Summary of safety and clinical performance'> Article 32</a>,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER III/Article 33 - European database on medical devices'> Article 33</a>(4),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">the second sentence of <a href='../CHAPTER IV/Article 40 - Nomination of experts for joint assessment of applications for notification'> Article 40</a>(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER IV/Article 42 - Designation and notification procedure'> Article 42</a>(10),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER IV/Article 43 - Identification number and list of notified bodies'> Article 43</a>(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">the second subparagraph&nbsp;of <a href='../CHAPTER IV/Article 44 - Monitoring and reassessment of notified bodies'> Article 44</a>(12),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">points (d) and (e) of <a href='../CHAPTER IV/Article 46 - Changes to designations and notifications'> Article 46</a>(7),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER V/Article 53 - Involvement of notified bodies in conformity assessment procedures'> Article 53</a>(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER V/Article 54 - Clinical evaluation consultation procedure for certain class III and class IIb devices'> Article 54</a>(3),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER V/Article 55 - Mechanism for scrutiny of conformity assessments of certain class III and class IIb devices'> Article 55</a>(1),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">Articles&nbsp;70 to 77,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">paragraphs 1 to 13 of <a href='../CHAPTER VI/Article 78 - Coordinated assessment procedure for clinical investigations'> Article 78</a>,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">Articles&nbsp;79 to 82,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER VII/Article 86 - Periodic safety update report'> Article 86</a>(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">Articles&nbsp;87 and 88,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER VII/Article 89 - Analysis of serious incidents and field safety corrective actions'> Article 89</a>(5) and (7), and the third subparagraph&nbsp;of <a href='../CHAPTER VII/Article 89 - Analysis of serious incidents and field safety corrective actions'> Article 89</a>(8),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER VII/Article 90 - Analysis of vigilance data'> Article 90</a>,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER VII/Article 93 - Market surveillance activities'> Article 93</a>(4), (7) and (8),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER VII/Article 95 - Procedure for dealing with devices presenting an unacceptable risk to health and safety'> Article 95</a>(2) and (4),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">the last sentence of <a href='../CHAPTER VII/Article 97 - Other noncompliance'> Article 97</a>(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list"><a href='../CHAPTER VII/Article 99 - Good administrative practice'> Article 99</a>(4),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">the second sentence of the first subparagraph&nbsp;of <a href='../CHAPTER X/Article 120 - Transitional provisions'> Article 120</a>(3).</div>
            </div>
         </div>
         <p class="list">Until Eudamed is fully functional, the 
corresponding provisions of Directives&nbsp;90/385/EEC and 93/42/EEC 
shall continue to apply for the purpose of meeting the obligations laid 
down in the provisions listed in the first paragraph&nbsp;of this point 
regarding exchange of information including, and in particular, 
information regarding vigilance reporting, clinical investigations, 
registration of devices and economic operators, and certificate 
notifications.</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(e)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm"><a href='../CHAPTER III/Article 29 - Registration of devices'> Article 29</a>(4) and <a href='../CHAPTER V/Article 56 - Certificates of conformity'> Article 56</a>(5) shall apply from 18 months after the later of the dates referred to in point&nbsp;(d);</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(f)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">for implantable devices and for class III 
devices <a href='../CHAPTER III/Article 27 - Unique Device Identification system'> Article 27</a>(4) shall apply from 26&nbsp;May 2021. For 
class&nbsp;IIa and class&nbsp;IIb devices <a href='../CHAPTER III/Article 27 - Unique Device Identification system'> Article 27</a>(4) shall apply
 from 26&nbsp;May 2023. For class I devices <a href='../CHAPTER III/Article 27 - Unique Device Identification system'> Article 27</a>(4) shall 
apply from 26&nbsp;May 2025;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(g)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">for reusable devices that shall bear the UDI 
carrier on the device itself, <a href='../CHAPTER III/Article 27 - Unique Device Identification system'> Article 27</a>(4) shall apply from two 
years after the date referred to in point&nbsp;(f) of this 
paragraph&nbsp;for the respective class of devices in that point;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(h)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">The procedure set out in <a href='../CHAPTER VI/Article 78 - Coordinated assessment procedure for clinical investigations'> Article 78</a> shall apply from 26 May 2027, without prejudice to <a href='../CHAPTER VI/Article 78 - Coordinated assessment procedure for clinical investigations'> Article 78</a>(14);</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(i)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm"><a href='../CHAPTER X/Article 120 - Transitional provisions'> Article 120</a>(12) shall apply from 26 May 2019.</p>
      </div>
 </div>